Search Results - "Villes, V"

Refine Results
  1. 1

    Need for integration of hepatitis C (HCV) services in community-based settings for people who inject drugs: results from a global values and preferences survey by Di Ciaccio, M, Villes, V, Perfect, C, El Kaim, J L, Donatelli, M, James, C, Easterbrook, P, Delabre, R M

    Published in Harm reduction journal (09-02-2023)
    “…To inform the development of updated World Health Organization (WHO) guidelines on simplified service delivery for HCV infection, a global survey was…”
    Get full text
    Journal Article
  2. 2

    COVID-19 vaccination intention among people who use drugs in France in 2021: results from the international community-based research program EPIC by Lacoux, C, Villes, V, Riegel, L, Coulmain, S, Lorente, N, Derras, S Eddine, Castro, D Rojas, Roux, P, Delabre, R M, Michels, D

    Published in Harm reduction journal (16-10-2024)
    “…COVID-19 vaccination is crucial to reduce the incidence of severe forms of the disease in the population. However, people who use drugs (PWUD) face structural…”
    Get full text
    Journal Article
  3. 3

    Female sex workers and police violence during the Covid-19 health crisis in 2020-2021: results from the EPIC multi-country community-based research program in Argentina by Aristegui, I, Castro Avila, J, Villes, V, Delabre, R M, Orellano, G, Aguilera, M, Romero, M, Riegel, L, Kretzer, L, Cardozo, N, Radusky, P D, Rojas Castro, D

    Published in Harm reduction journal (12-12-2022)
    “…Female sex workers (FSW) have been disproportionately impacted by the Covid-19 crisis. Data show increases of police violence toward key populations (KP),…”
    Get full text
    Journal Article
  4. 4

    Pelvic fracture in multiple trauma: A 67-case series by Caillot, M, Hammad, E, Le Baron, M, Villes, V, Leone, M, Flecher, X

    “…Abstract Introduction Severe pelvic trauma remains associated with elevated mortality, largely due to hemorrhagic shock. Objective The main study objective was…”
    Get full text
    Journal Article
  5. 5

    Buprenorphine in primary care: Risk factors for treatment injection and implications for clinical management by Roux, Perrine, Villes, Virgine, Blanche, Jerome, Bry, Didier, Spire, Bruno, Feroni, Isabelle, Carrieri, M. Patrizia

    Published in Drug and alcohol dependence (01-09-2008)
    “…Abstract Aims Though the introduction of office-based buprenorphine has greatly contributed to stem the HIV epidemic since 1995, concerns have been raised…”
    Get full text
    Journal Article
  6. 6

    Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008 by Michel, L., Villes, V., Dabis, F., Spire, B., Winnock, M., Loko, M.-A., Poizot-Martin, I., Valantin, M. A., Bonnard, P., Salmon-Céron, D., Carrieri, M. P.

    Published in Journal of viral hepatitis (01-09-2010)
    “…Fatigue is a major component of quality of life (QOL) and is associated with depression in HIV–HCV co‐infected individuals. We investigated whether treating…”
    Get full text
    Journal Article
  7. 7

    Dépistage communautaire et facteurs associés au VIH d’hommes ayant des relations sexuelles avec des hommes (HSH) en Haïti entre 2015 et 2018 by Alain, T

    “…Les hommes ayant des relations sexuelles avec des hommes (HSH) constituent une population clé du virus de l’immunodéficience humaine (VIH) en Haïti. Cependant,…”
    Get full text
    Journal Article
  8. 8

    Is long‐term virological response related to CCR5 Δ32 deletion in HIV‐1‐infected patients started on highly active antiretroviral therapy? by Laurichesse, J‐J, Taieb, A, Capoulade‐Metay, C, Katlama, C, Villes, V, Drobacheff‐Thiebaud, M‐C, Raffi, F, Chêne, G, Theodorou, I, Leport, C

    Published in HIV medicine (01-04-2010)
    “…Objective The aim of the study was to determine whether the chemokine (C‐C motif) receptor 5 (CCR5) Δ32 deletion is associated with long‐term response to…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Community-Based Testing and Factors Associated with HIV among Men Who Have Sex with Men (MSM) in Haiti between 2015 and 2018 by Alain, T, Villes, V, Mérisier, J-M, Dimanche, V, Quatremère, G, Audemard, C, Lustin, S, Jeudy, C, Erol, J, Descardes, A, Michels, D, Rojas Castro, D

    “…Men who have sex with men (MSM) are an HIV key population in Haiti. However, little data exists on that population and on factors associated with this…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Living with HIV, antiretroviral treatment experience and tobacco smoking : results from a multisite cross-sectional study by DUVAL, Xavier, BARON, Gabriel, GARELIK, Daniel, VILLES, Virginie, DUPRE, Thierry, LEPORT, Catherine, LERT, France, PERETTI-WATEL, Patrick, RAVAUD, Philippe, SPIRE, Bruno

    Published in Antiviral therapy (01-01-2008)
    “…To assess the prevalence of and factors associated with tobacco smoking and dependence in HIV patients. In a one-day cross-sectional national survey of a…”
    Get full text
    Journal Article
  15. 15

    Health related quality of life among HIV-HCV co-infected patients by Préau, M, Protopopescu, C, Spire, B, Dellamonica, P, Poizot-Martin, I, Villes, V, Carrieri, M P

    “…To assess factors associated with higher levels of health-related quality-of-life among HIV-HCV co-infected injecting drug users and more specifically, to…”
    Get more information
    Journal Article
  16. 16

    Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults by Collin, F, Duval, X, Le Moing, V, Piroth, L, Kaied, F A, Massip, P, Villes, V, Chene, G, Raffi, F

    Published in AIDS (London) (15-05-2009)
    “…In the ANRS CO8 APROCO-COPILOTE cohort of patients treated with combination antiretroviral therapy since 1997-1999, the incidence density of bone fractures was…”
    Get full text
    Journal Article
  17. 17

    Buprenorphine sniffing as a response to inadequate care in substituted patients: Results from the Subazur survey in south-eastern France by Roux, P, Villes, V, Bry, D, Spire, B, Feroni, I, Marcellin, F, Carrieri, M P

    Published in Addictive behaviors (01-12-2008)
    “…Background: Despite the safety profile of buprenorphine, which makes this treatment highly acceptable for many countries, the risk of its diversion raises…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Is long-term virological response related to CCR5 32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy? by Laurichesse, J-J, Taieb, A, Capoulade-Metay, C, Katlama, C, Villes, V, Drobacheff-Thiebaud, M-C, Raffi, F, Chene, G, Theodorou, I, Leport, C

    Published in HIV medicine (01-04-2010)
    “…ObjectiveThe aim of the study was to determine whether the chemokine (C-C motif) receptor 5 (CCR5) 32 deletion is associated with long-term response to…”
    Get full text
    Journal Article
  20. 20

    Prevalence and Predictors of Deterioration of a Trustful Patient-Provider Relationship Among HIV-lnfected Persons Treated With Antiretrovlral Therapy by Pneau, M, Leport, C, Villes, V, Michelet, C, Collin, F, Carrieri, M-P, Ragnaud, J-M, Taieb, A, Raffi, F, Spire, B

    “…Objectives: We studied the evolution of the patient-provider relationship (PPR) in HIV-infected patients who reported trustful relationships at highly active…”
    Get full text
    Journal Article